Trump claims COVID-19 is 'going away' as Biden argues masks could 'save 100,000 lives'


President Trump and Democratic presidential candidate Joe Biden offered dueling approaches to tackling the coronavirus crisis during their opening comments at the final presidential debate on Thursday.
Trump opened the night by touting his response to the pandemic, claiming that 2.2 million people had initially been "expected to die," quoting a worst-case scenario projection if the government had done nothing to stop the spread of the virus. Trump also downplayed spikes around the country, claiming "it will go away. We're rounding the turn. We're rounding the corner. It's going away."
Biden painted a different picture, describing a "dark winter" ahead for America if more robust action isn't taken to stop the spread of the disease. "Over 200,000 Americans are dead," Biden said. "If we just wore these masks, the president's own advisers told us, we could save 100,000 lives. And we're in a circumstance where the president still has no comprehensive plan."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Biden appeared to be once again citing the University of Washington's Institute for Health Metrics and Evaluation forecast, which said as of September that "224,000 more people in the U.S. could die from the coronavirus by January, but with near-universal mask use the number of projected additional fatalities could decrease by more than half, or at least 100,000," CNN reports.
“I will take care of this. I will end this," Biden concluded. "I will make sure we have a plan." Jeva Lange
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
Today's political cartoons - March 22, 2025
Cartoons Saturday's cartoons - silenced voices, DOGE backlash, and more
By The Week US Published
-
5 crazed cartoons about March Madness
Cartoons Artists take on the education bracket, apolitical moments, and more
By The Week US Published
-
Elon Musk: has he made Tesla toxic?
Talking Point Musk's political antics have given him the 'reverse Midas touch' when it comes to his EV empire
By The Week UK Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published